116 related articles for article (PubMed ID: 37321470)
1. Oridonin inhibits the occurrence and development of colorectal cancer by reversing the Warburg effect via reducing PKM2 dimer formation and preventing its entry into the nucleus.
Chen F; Liao J; Wu P; Cheng L; Ma Y; Zhang L; Leng X; Zhu X; Liu Z; Xie F
Eur J Pharmacol; 2023 Sep; 954():175856. PubMed ID: 37321470
[TBL] [Abstract][Full Text] [Related]
2. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
Pi J; Jiang J; Cai H; Yang F; Jin H; Yang P; Cai J; Chen ZW
Drug Deliv; 2017 Nov; 24(1):1549-1564. PubMed ID: 29019267
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
[TBL] [Abstract][Full Text] [Related]
4. Oridonin inhibits gefitinib-resistant lung cancer cells by suppressing EGFR/ERK/MMP-12 and CIP2A/Akt signaling pathways.
Xiao X; He Z; Cao W; Cai F; Zhang L; Huang Q; Fan C; Duan C; Wang X; Wang J; Liu Y
Int J Oncol; 2016 Jun; 48(6):2608-18. PubMed ID: 27082429
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling.
Liu RX; Ma Y; Hu XL; Ren WY; Liao YP; Wang H; Zhu JH; Wu K; He BC; Sun WJ
Int J Oncol; 2018 Nov; 53(5):2091-2101. PubMed ID: 30132514
[TBL] [Abstract][Full Text] [Related]
6. Oridonin inhibits the proliferation of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
Liu Y; Liu YZ; Zhang RX; Wang X; Meng ZJ; Huang J; Wu K; Luo JY; Zuo GW; Chen L; Yin LJ; Deng ZL; He BC
Int J Oncol; 2014 Aug; 45(2):795-803. PubMed ID: 24859848
[TBL] [Abstract][Full Text] [Related]
7. ERK/PKM2 Is Mediated in the Warburg Effect and Cell Proliferation in Arsenic-Induced Human L-02 Hepatocytes.
Yin F; Zhang X; Zhang Z; Zhang M; Yin Y; Yang Y; Gao Y
Biol Trace Elem Res; 2024 Feb; 202(2):493-503. PubMed ID: 37237135
[TBL] [Abstract][Full Text] [Related]
8. Oridonin inhibits the proliferation of human colon cancer cells by upregulating BMP7 to activate p38 MAPK.
Ren CM; Li Y; Chen QZ; Zeng YH; Shao Y; Wu QX; Yuan SX; Yang JQ; Yu Y; Wu K; He BC; Sun WJ
Oncol Rep; 2016 May; 35(5):2691-8. PubMed ID: 26986967
[TBL] [Abstract][Full Text] [Related]
9. Induction of Apoptosis in Human Leukemic Cell Lines by Diallyl Disulfide via Modulation of EGFR/ERK/PKM2 Signaling Pathways.
Luo N; Zhao LC; Shi QQ; Feng ZQ; Chen DL; Li J
Asian Pac J Cancer Prev; 2015; 16(8):3509-15. PubMed ID: 25921170
[TBL] [Abstract][Full Text] [Related]
10. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects.
Li J; Wu Y; Wang D; Zou L; Fu C; Zhang J; Leung GP
Pharmacol Res; 2019 Aug; 146():104313. PubMed ID: 31202781
[TBL] [Abstract][Full Text] [Related]
11. MNX1-AS1, a c-Myc induced lncRNA, promotes the Warburg effect by regulating PKM2 nuclear translocation.
Wu Y; Wang Y; Yao H; Li H; Meng F; Li Q; Lin X; Liu L
J Exp Clin Cancer Res; 2022 Dec; 41(1):337. PubMed ID: 36476366
[TBL] [Abstract][Full Text] [Related]
12. Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions.
Bi YH; Han WQ; Li RF; Wang YJ; Du ZS; Wang XJ; Jiang Y
World J Gastroenterol; 2019 Apr; 25(16):1936-1949. PubMed ID: 31086462
[TBL] [Abstract][Full Text] [Related]
13. Oridonin up-regulates expression of P21 and induces autophagy and apoptosis in human prostate cancer cells.
Li X; Li X; Wang J; Ye Z; Li JC
Int J Biol Sci; 2012; 8(6):901-12. PubMed ID: 22745580
[TBL] [Abstract][Full Text] [Related]
14. Beta-elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation.
Pan Y; Wang W; Huang S; Ni W; Wei Z; Cao Y; Yu S; Jia Q; Wu Y; Chai C; Zheng Q; Zhang L; Wang A; Sun Z; Huang S; Wang S; Chen W; Lu Y
J Cell Mol Med; 2019 Oct; 23(10):6846-6858. PubMed ID: 31343107
[TBL] [Abstract][Full Text] [Related]
15. Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway.
Liu QQ; Chen K; Ye Q; Jiang XH; Sun YW
Cancer Cell Int; 2016; 16():57. PubMed ID: 27453691
[TBL] [Abstract][Full Text] [Related]
16. Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells.
Yao Z; Xie F; Li M; Liang Z; Xu W; Yang J; Liu C; Li H; Zhou H; Qu LH
Cell Death Dis; 2017 Feb; 8(2):e2633. PubMed ID: 28230866
[TBL] [Abstract][Full Text] [Related]
17. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect.
Yang W; Zheng Y; Xia Y; Ji H; Chen X; Guo F; Lyssiotis CA; Aldape K; Cantley LC; Lu Z
Nat Cell Biol; 2012 Dec; 14(12):1295-304. PubMed ID: 23178880
[TBL] [Abstract][Full Text] [Related]
18. Oridonin promotes endoplasmic reticulum stress via TP53-repressed TCF4 transactivation in colorectal cancer.
Zhou F; Gao H; Shang L; Li J; Zhang M; Wang S; Li R; Ye L; Yang S
J Exp Clin Cancer Res; 2023 Jun; 42(1):150. PubMed ID: 37337284
[TBL] [Abstract][Full Text] [Related]
19. Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer.
Li Q; Zhang D; Chen X; He L; Li T; Xu X; Li M
Sci Rep; 2015 Nov; 5():16082. PubMed ID: 26542452
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel modified dual-target shikonin derivatives for colorectal cancer treatment.
Ma Y; Lai X; Wen Z; Zhou Z; Yang M; Chen Q; Wang X; Mei F; Yang L; Yin T; Sun S; Lu G; Qi J; Lin H; Han H; Yang Y
Bioorg Chem; 2023 Oct; 139():106703. PubMed ID: 37399615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
